PANCREATIC DUCT STENOSIS

This adverse event was reported 91 times

These drugs are most commonly taken by patients reporting PANCREATIC DUCT STENOSIS:

# Drug Count
0 ADALIMUMAB 16
1 FOLIC ACID 10
2 PANTOPRAZOLE 10
3 SIMVASTATIN 10
4 PANCRELIPASE 9
5 BISOPROLOL FUMARATE 8
6 ASPIRIN 7
7 ASPIRIN 325 MG 7
8 ASPIRIN 81 MG 7
9 GABAPENTIN 7
See all common drugs associated with PANCREATIC DUCT STENOSIS

PANCREATIC DUCT STENOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 METEX 1 0.0026
1 BODY CLEANSER 1 0.0014
2 CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE 2 0.0010
3 CEFTOLOZANE AND TAZOBACTAM 1 0.0010
4 SKIN PROTECTANT 2 0.0007
5 WHITE PETROLATUM 1 0.0007
6 NIZATIDINE 1 0.0007
7 CASPOFUNGIN ACETATE 1 0.0006
8 BELZUTIFAN 1 0.0006
9 UREA 1 0.0005
See all drugs enriched for association with PANCREATIC DUCT STENOSIS

PANCREATIC DUCT STENOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Antihypoglycemic Agent [EPC] 1 0.0002
1 GLP-2 Analog [EPC] 2 0.0001
2 Somatostatin Analog [EPC] 1 0.0001
3 Tetracycline-class Antibacterial [EPC] 1 0.0001
4 Provitamin D2 Compound [EPC] 3 0.0001
5 Aluminum Complex [EPC] 2 0.0001
6 Phenothiazine [EPC] 2 0.0001
7 Insulin [EPC] 2 0.0000
8 Prostacyclin Receptor Agonist [EPC] 1 0.0000
9 Interleukin-23 Antagonist [EPC] 4 0.0000
See all drug classes enriched for association with PANCREATIC DUCT STENOSIS